Institutional investors hold a majority ownership of GRFS through the 60.79% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended December 2017, these large investors purchased a net $3.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ALLIANCEBERNSTEIN LTD. Bought 342.5 Thousand shares of Grifols SA
CTC MYCFO LLC Bought 9.3 Thousand shares of Grifols SA
BMO PRIVATE INVESTMENT COUNSEL, ... Bought 8.3 Thousand shares of Grifols SA